Axonics, Inc. AXNX has received regulatory approval from the Therapeutic Goods Administration (TGA) to market its R20 rechargeable sacral neuromodulation (SNM) system in Australia. This cutting-edge ...
Boston Scientific is taking clear steps to advance its European, Middle East and Africa (EMEA) region market position in the ...
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics F15™ ...
Axonics devices are implanted to help control incontinence and can last as long as 17 to 24 years or more Boston Scientific Corp. (NYSE: BSX) announced that it has closed on its acquisition of ...
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics R20 ® ...
It’s finally over. Medtronic and Boston Scientific’s Axonics longstanding patent battle is finished. The companies settled the legal spat over patent infringements related to sacral neuromodulation ...
Boston Scientific Corporation BSX recently closed the acquisition of Axonics, Inc., a medical technology company focused on the development and commercialization of differentiated devices to treat ...
When Raymond Cohen saw an ad for his company Axonics Inc. play on national television during a run of Jeopardy!, it was a surreal moment for him. He never imagined one of his business ventures gaining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results